Seminar in writing Open Access February 03, 2023

Novel nano-thermal ablation therapy using functionalized heat-generating nanoparticles for solid cancer treatment

1
Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
2
Department of Chemical Systems Engineering, School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan
3
Emeritus professor, School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan
Page(s): 29-46
Received
December 25, 2022
Revised
January 24, 2023
Accepted
February 01, 2023
Published
February 03, 2023
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2023. Published by Scientific Publications
Article metrics
Views
498
Downloads
197

Cite This Article

APA Style
Morino, T. , Morino, T. Kawai, N. , Kawai, N. Ito, A. , Ito, A. Kobayashi, T. , & Kobayashi, T. (2023). Novel nano-thermal ablation therapy using functionalized heat-generating nanoparticles for solid cancer treatment. Universal Journal of Pharmacy and Pharmacology, 2(1), 29-46. https://doi.org/10.31586/wjcor.2023.592
ACS Style
Morino, T. ; Morino, T. Kawai, N. ; Kawai, N. Ito, A. ; Ito, A. Kobayashi, T. ; Kobayashi, T. Novel nano-thermal ablation therapy using functionalized heat-generating nanoparticles for solid cancer treatment. Universal Journal of Pharmacy and Pharmacology 2023 2(1), 29-46. https://doi.org/10.31586/wjcor.2023.592
Chicago/Turabian Style
Morino, Tomio, Tomio Morino. Noriyasu Kawai, Noriyasu Kawai. Akira Ito, Akira Ito. Takeshi Kobayashi, and Takeshi Kobayashi. 2023. "Novel nano-thermal ablation therapy using functionalized heat-generating nanoparticles for solid cancer treatment". Universal Journal of Pharmacy and Pharmacology 2, no. 1: 29-46. https://doi.org/10.31586/wjcor.2023.592
AMA Style
Morino T, Morino TKawai N, Kawai NIto A, Ito AKobayashi T, Kobayashi T. Novel nano-thermal ablation therapy using functionalized heat-generating nanoparticles for solid cancer treatment. Universal Journal of Pharmacy and Pharmacology. 2023; 2(1):29-46. https://doi.org/10.31586/wjcor.2023.592
@Article{ujpp592,
AUTHOR = {Morino, Tomio and Kawai, Noriyasu and Ito, Akira and Kobayashi, Takeshi and Yasui, Takahiro},
TITLE = {Novel nano-thermal ablation therapy using functionalized heat-generating nanoparticles for solid cancer treatment},
JOURNAL = {Universal Journal of Pharmacy and Pharmacology},
VOLUME = {2},
YEAR = {2023},
NUMBER = {1},
PAGES = {29-46},
URL = {https://www.scipublications.com/journal/index.php/WJCOR/article/view/592},
ISSN = {2834-5436},
DOI = {10.31586/wjcor.2023.592},
ABSTRACT = {This seminar in writing introduced novel cancer thermal therapy using functionalized heat-generating nanoparticles with about 100 nm diameter, administered via intratumor injection. The nanoparticles named magnetites cationic lipid composite particles (MCL particles) were composed of about 10 nm magnetites (Fe3O4), a cationic lipid and two neutral lipids. Magnetites in MCL particles generated heat due to external alternating magnetic field (AMF) irradiation to kill cancer cells nearby located. A cationic lipid component conferred several functions to MCL particles necessary for its efficacy and safety. Origination of the therapy with MCL particles was summarized by referring to our earlier reports in 1996-2014. Further characterizations of MCP particles and utility of heat dose index for treatment control were summarized by referring to our recent reports in 2019-2022. Unpublished data were supplemented to support overall understanding of the therapy. Purpose of this seminar is to clarify novel principle of the therapy in comparison with conventional thermal therapies and to discuss its clinical application.},
}
%0 Journal Article
%A Morino, Tomio
%A Kawai, Noriyasu
%A Ito, Akira
%A Kobayashi, Takeshi
%A Yasui, Takahiro
%D 2023
%J Universal Journal of Pharmacy and Pharmacology

%@ 2834-5436
%V 2
%N 1
%P 29-46

%T Novel nano-thermal ablation therapy using functionalized heat-generating nanoparticles for solid cancer treatment
%M doi:10.31586/wjcor.2023.592
%U https://www.scipublications.com/journal/index.php/WJCOR/article/view/592
TY  - JOUR
AU  - Morino, Tomio
AU  - Kawai, Noriyasu
AU  - Ito, Akira
AU  - Kobayashi, Takeshi
AU  - Yasui, Takahiro
TI  - Novel nano-thermal ablation therapy using functionalized heat-generating nanoparticles for solid cancer treatment
T2  - Universal Journal of Pharmacy and Pharmacology
PY  - 2023
VL  - 2
IS  - 1
SN  - 2834-5436
SP  - 29
EP  - 46
UR  - https://www.scipublications.com/journal/index.php/WJCOR/article/view/592
AB  - This seminar in writing introduced novel cancer thermal therapy using functionalized heat-generating nanoparticles with about 100 nm diameter, administered via intratumor injection. The nanoparticles named magnetites cationic lipid composite particles (MCL particles) were composed of about 10 nm magnetites (Fe3O4), a cationic lipid and two neutral lipids. Magnetites in MCL particles generated heat due to external alternating magnetic field (AMF) irradiation to kill cancer cells nearby located. A cationic lipid component conferred several functions to MCL particles necessary for its efficacy and safety. Origination of the therapy with MCL particles was summarized by referring to our earlier reports in 1996-2014. Further characterizations of MCP particles and utility of heat dose index for treatment control were summarized by referring to our recent reports in 2019-2022. Unpublished data were supplemented to support overall understanding of the therapy. Purpose of this seminar is to clarify novel principle of the therapy in comparison with conventional thermal therapies and to discuss its clinical application.
DO  - Novel nano-thermal ablation therapy using functionalized heat-generating nanoparticles for solid cancer treatment
TI  - 10.31586/wjcor.2023.592
ER  -